-
Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases
-
Changhyeok Hwang, Young Hoon Youn, Sung-eun Choi, Young Hak Jung, Hae Yeul Park, Jae Jun Park, Jie Hyun Kim, Hyojin Park
-
Clin Endosc 2015;48(6):553-557. Published online November 30, 2015
-
DOI: https://doi.org/10.5946/ce.2015.48.6.553
-
-
 Abstract
 PDF PubReader ePub
- We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.
-
Citations
Citations to this article as recorded by  - Clinical efficacy of endoscopic submucosal dissection in the treatment of early esophageal cancer and precancerous lesions
Yue Wu, Haihui Zhang, Bingxi Zhou, Shuangyin Han, Yanrui Zhang
Journal of Cancer Research and Therapeutics.2018; 14(1): 52. CrossRef
-
8,308
View
-
66
Download
-
2
Web of Science
-
1
Crossref
|
KSGE
